All hedge funds or institutions that manage over $100M are required by the SEC to file quarterly reports on their holdings.
These reports are called 13F reports. However, the filings are required
the following quarter
from the reporting period,
which means that by the time the filing is made (and we see them), the information could be five months old.
For funds
with long term positions that make few trades, the holdings might closely resemble their current holdings, even after several months. However, for funds that have high turnover,
the holdings data we see might differ significantly from their current holdings. Institutions are required to report CALL and PUT options, and those positions
are identified in the table. However, they are not required to report short positions.
Click the link icon to see the full transaction history.
Upgrade
to unlock premium data and export to Excel
.
Security |
Imputed Share Price |
Prev Shares |
Current Shares |
Change (Percent) |
Prev Value (USD x1000) |
Current Value (USD x1000) |
Change (Percent) |
CERS / Cerus Corporation
|
|
|
|
|
|
|
|
/ Achaogen Inc
|
|
|
|
|
|
|
|
KYTH / Kythera Biopharma
|
|
|
|
|
|
|
|
XNPT / XenoPort, Inc.
|
|
|
|
|
|
|
|
MNKKQ / Mallinckrodt Plc
|
|
|
|
|
|
|
|
AERI / Aerie Pharmaceuticals Inc
|
|
|
|
|
|
|
|
NLTX / Neoleukin Therapeutics, Inc.
|
|
|
|
|
|
|
|
GEVA / Synageva Biopharma Corp
|
|
|
|
|
|
|
|
KPTI / Karyopharm Therapeutics Inc.
|
|
|
|
|
|
|
|
PCYC / Pharmacyclics
|
|
|
|
|
|
|
|
ABUS / Arbutus Biopharma Corporation
|
|
|
|
|
|
|
|
RIGL / Rigel Pharmaceuticals, Inc.
|
|
|
|
|
|
|
|
CYCCP / Cyclacel Pharmaceuticals, Inc. - Preferred Stock
|
|
|
|
|
|
|
|
SLXP / Salix Therapeuticals, Inc.
|
|
|
|
|
|
|
|
CNCE / Concert Pharmaceuticals Inc
|
|
|
|
|
|
|
|
LPCN / Lipocine Inc.
|
|
|
|
|
|
|
|
TSRO / TESARO, Inc.
|
|
|
|
|
|
|
|
02318X100 / Ambit Biosciences Corp
|
|
|
|
|
|
|
|
IRWD / Ironwood Pharmaceuticals, Inc.
|
|
|
|
|
|
|
|
ZGNX / Zogenix Inc
|
|
|
|
|
|
|
|
FMI / Foundation Medicine, Inc.
|
|
|
|
|
|
|
|
BTX.WS / BioTime, Inc. Warrants exp. 2018-10-01
|
|
|
|
|
|
|
|
XOMA / XOMA Royalty Corporation
|
|
|
|
|
|
|
|
PTN / Palatin Technologies, Inc.
|
|
|
|
|
|
|
|
ARCT / Arcturus Therapeutics Holdings Inc.
|
|
|
|
|
|
|
|
OSIR / Osiris Therapeutics, Inc.
|
|
|
|
|
|
|
|
58501NAA9 / Medivation, Inc. 2.625% Bond 4/1/17
|
|
|
|
|
|
|
|
45337CAK8 / Incyte Corporation Bonds 0.375% 11/15/2018
|
|
|
|
|
|
|
|
WINT / Windtree Therapeutics, Inc.
|
|
|
|
|
|
|
|
OSUR / OraSure Technologies, Inc.
|
|
|
|
|
|
|
|
795435AE6 / Salix Pharmaceuticals Inc. Bond 1.5% 3/15/19
|
|
|
|
|
|
|
|
NVLN / NOVELION THERAPEUTICS INC.
|
|
|
|
|
|
|
|
09061GAD3 / BioMarin Pharmaceutical Inc. Bond 1.875% 4/23/2017
|
|
|
|
|
|
|
|
375558AP8 / Gilead Sciences, Inc. Bond 1.625% 5/1/16
|
|
|
|
|
|
|
|
JUNO / Juno Therapeutics, Inc.
|
|
|
|
|
|
|
|
SVRA / Savara Inc.
|
|
|
|
|
|
|
|
451731103 / Ignyta, Inc.
|
|
|
|
|
|
|
|
MDWD / MediWound Ltd.
|
|
|
|
|
|
|
|
NDRM / NeuroDerm Ltd.
|
|
|
|
|
|
|
|
OCX / OncoCyte Corporation
|
|
|
|
|
|
|
|
Salix 2.75% 5/15/15
/ CONV BONDS (795435AC0) |
|
|
|
|
|
|
|
Arrowhead Research Corp.
/ (042797209) |
|
|
|
|
|
|
|
74365AAB7 / Protalix BioTherapeutics, Inc. Bonds 4.5% 9/15/18
|
|
|
|
|
|
|
|
45337CAJ1 / Incyte Corporation Bonds 4.75% 10/1/2015
|
|
|
|
|
|
|
|
PRQR / ProQR Therapeutics N.V.
|
|
|
|
|
|
|
|
PGNX / Progenics Pharmaceuticals, Inc.
|
|
|
|
|
|
|
|
US00448Q2012 / Achillion Pharmaceuticals, Inc.
|
|
|
|
|
|
|
|
09061GAE1 / BioMarin Pharmaceutical Inc. Bond 0.75% 10/15/2018
|
|
|
|
|
|
|
|
TARA / Protara Therapeutics, Inc.
|
|
|
|
|
|
|
|
BCRX / BioCryst Pharmaceuticals, Inc.
|
|
|
|
|
|
|
|
LGND / Ligand Pharmaceuticals Incorporated
|
|
|
|
|
|
|
|
DERM / Journey Medical Corporation
|
|
|
|
|
|
|
|
ALNY / Alnylam Pharmaceuticals, Inc.
|
|
|
|
|
|
|
|
FOLD / Amicus Therapeutics, Inc.
|
|
|
|
|
|
|
|
DSCI / Derma Sciences, Inc.
|
|
|
|
|
|
|
|
INCY / Incyte Corporation
|
|
|
|
|
|
|
|
RCPT / Receptos, Inc.
|
|
|
|
|
|
|
|
INSM / Insmed Incorporated
|
|
|
|
|
|
|
|
IDRA / Idera Pharmaceuticals, Inc.
|
|
|
|
|
|
|
|
FOMX / Foamix Pharmaceuticals Ltd.
|
|
|
|
|
|
|
|
SGMO / Sangamo Therapeutics, Inc.
|
|
|
|
|
|
|
|
TGTX / TG Therapeutics, Inc.
|
|
|
|
|
|
|
|
STML / Stemline Therapeutics, Inc.
|
|
|
|
|
|
|
|
AVNR / Avanir Pharmaceuticals Inc
|
|
|
|
|
|
|
|
AVNR / Avanir Pharmaceuticals Inc Call
|
|
|
|
|
|
|
|
HALO / Halozyme Therapeutics, Inc.
|
|
|
|
|
|
|
|
CYTR / LadRx Corp
|
|
|
|
|
|
|
|
ZIOP / Alaunos Therapeutics Inc
|
|
|
|
|
|
|
|
CLTX / Celsus Therapeutics
|
|
|
|
|
|
|
|
GILD / Gilead Sciences, Inc.
|
|
|
|
|
|
|
|
GHDX / Genomic Health, Inc.
|
|
|
|
|
|
|
|
76028H209 / Repros Therapeutics, Inc.
|
|
|
|
|
|
|
|
ALDR / Alder BioPharmaceuticals, Inc.
|
|
|
|
|
|
|
|
CLVS / Clovis Oncology Inc
|
|
|
|
|
|
|
|
VXRT / Vaxart, Inc.
|
|
|
|
|
|
|
|
DYAX / Dyax Corp.
|
|
|
|
|
|
|
|
45337CAL6 / Incyte Corporation Bonds 1.25% 11/15/2020
|
|
|
|
|
|
|
|
BDSI / Biodelivery Sciences International
|
|
|
|
|
|
|
|
US00484MAA45 / Acorda Therapeutics, Inc. Bond 1.750% 6/1
|
|
|
|
|
|
|
|
SGYPQ / SYNERGY PHARMACEUTICALS INC DEL
|
|
|
|
|
|
|
|
EPZM / Epizyme Inc
|
|
|
|
|
|
|
|
QURE / uniQure N.V.
|
|
|
|
|
|
|
|
CMRX / Chimerix, Inc.
|
|
|
|
|
|
|
|
INFI / Infinity Pharmaceuticals Inc.
|
|
|
|
|
|
|
|
LOXO / Loxo Oncology, Inc.
|
|
|
|
|
|
|
|
GERN / Geron Corporation
|
|
|
|
|
|
|
|
MRNS / Marinus Pharmaceuticals, Inc.
|
|
|
|
|
|
|
|
AUPH / Aurinia Pharmaceuticals Inc.
|
|
|
|
|
|
|
|
/ Array BioPharma, Inc.
|
|
|
|
|
|
|
|
ISEE / IVERIC bio Inc
|
|
|
|
|
|
|
|
US33830X1046 / Five Prime Therapeutics Inc
|
|
|
|
|
|
|
|
MGNX / MacroGenics, Inc.
|
|
|
|
|
|
|
|
APTO / Aptose Biosciences Inc.
|
|
|
|
|
|
|
|
EIGR / Eiger BioPharmaceuticals, Inc.
|
|
|
|
|
|
|
|
XLRN / Acceleron Pharma Inc
|
|
|
|
|
|
|
|
MTEM / Molecular Templates, Inc.
|
|
|
|
|
|
|
|
VNDA / Vanda Pharmaceuticals Inc.
|
|
|
|
|
|
|
|
LJPC / La Jolla Pharmaceutical Co.
|
|
|
|
|
|
|
|
OMER / Omeros Corporation
|
|
|
|
|
|
|
|
CPRX / Catalyst Pharmaceuticals, Inc.
|
|
|
|
|
|
|
|
ACOR / Acorda Therapeutics, Inc.
|
|
|
|
|
|
|
|
032420101 / Anacor Pharmaceuticals, Inc.
|
|
|
|
|
|
|
|
BLUE / bluebird bio, Inc.
|
|
|
|
|
|
|
|
CCXI / ChemoCentryx Inc
|
|
|
|
|
|
|
|
ARAV / Aravive, Inc.
|
|
|
|
|
|
|
|
RARE / Ultragenyx Pharmaceutical Inc.
|
|
|
|
|
|
|
|
SAGE / Sage Therapeutics, Inc.
|
|
|
|
|
|
|
|
ENTA / Enanta Pharmaceuticals, Inc.
|
|
|
|
|
|
|
|
HRTX / Heron Therapeutics, Inc.
|
|
|
|
|
|
|
|
NVAX / Novavax, Inc.
|
|
|
|
|
|
|
|
NBIX / Neurocrine Biosciences, Inc.
|
|
|
|
|
|
|
|
AGIO / Agios Pharmaceuticals, Inc.
|
|
|
|
|
|
|
|
BMRN / BioMarin Pharmaceutical Inc.
|
|
|
|
|
|
|
|
MDGL / Madrigal Pharmaceuticals, Inc.
|
|
|
|
|
|
|
|
AFMD / Affimed N.V.
|
|
|
|
|
|
|
|
BLCM / Bellicum Pharmaceuticals, Inc.
|
|
|
|
|
|
|
|
SGEN / Seagen Inc
|
|
|
|
|
|
|
|
DBVT / DBV Technologies S.A. - Depositary Receipt (Common Stock)
|
|
|
|
|
|
|
|
XNCR / Xencor, Inc.
|
|
|
|
|
|
|
|
IONS / Ionis Pharmaceuticals, Inc.
|
|
|
|
|
|
|
|
MRTX / Mirati Therapeutics, Inc.
|
|
|
|
|
|
|
|
VIRX / Viracta Therapeutics, Inc.
|
|
|
|
|
|
|
|
ACAD / ACADIA Pharmaceuticals Inc.
|
|
|
|
|
|
|
|